Psychemedics Corporation (PMD) Financials
Stock symbol PMD is outdated, potentially delisted? Maybe it is available on other exchange?
PMD Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 14.1 million | 6.7 million |
| June 30, 2023 | 16.4 million | 7.3 million |
| March 31, 2023 | 17.9 million | 7.7 million |
| Dec. 31, 2022 | 18.7 million | 8.0 million |
PMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -993000 | 401000 |
| June 30, 2023 | -1.0 million | 143000 |
| March 31, 2023 | -266000 | 177000 |
| Dec. 31, 2022 | 1.9 million | 178000 |
PMD Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Sept. 30, 2023 | -2.1 million |
| June 30, 2023 | -726000 |
| March 31, 2023 | -384000 |
| Dec. 31, 2022 | -688000 |
PMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 1.4 million | - | 2.3 million |
| June 30, 2023 | 2.4 million | - | 2.5 million |
| March 31, 2023 | 4.4 million | - | 2.8 million |
| Dec. 31, 2022 | 4.8 million | - | 3.0 million |
PMD Shares Outstanding
PMD Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | 35000 | 275000 | 2.2 million | 723000 |
| June 30, 2023 | 56000 | 286000 | 1.4 million | 746000 |
| March 31, 2023 | 41000 | 298000 | 1.6 million | 789000 |
| Dec. 31, 2022 | 24000 | 323000 | 1.5 million | 781000 |
PMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | 5.7 million | 3.6 million |
| June 30, 2023 | 5.5 million | 3.5 million |
| March 31, 2023 | 5.9 million | 3.7 million |
| Dec. 31, 2022 | 5.7 million | 3.5 million |
PMD
Price: $2.67
52 week price:
Earnings Per Share: -0.51 USD
P/E Ratio: -4.46
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1100
Ebitda: 14.3 millionMarket Capitalization: 15.7 million
Average Dividend Frequency: 4